Post-transcriptional regulation of 5-lipoxygenase mRNA expression via alternative splicing and nonsense-mediated mRNA decay by Ochs, Meike et al.
Post-Transcriptional Regulation of 5-Lipoxygenase
mRNA Expression via Alternative Splicing and Nonsense-
Mediated mRNA Decay
Meike J. Ochs
1,2, Bernd L. Sorg
1, Laura Pufahl
1, Manuel Grez
3, Beatrix Suess
2*, Dieter Steinhilber
1*
1Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Frankfurt, Germany, 2Institute of Molecular Biosciences, Goethe University Frankfurt, Frankfurt,
Germany, 3Georg-Speyer-Haus, Frankfurt, Germany
Abstract
5-Lipoxygenase (5-LO) catalyzes the two initial steps in the biosynthesis of leukotrienes (LT), a group of inflammatory lipid
mediators derived from arachidonic acid. Here, we investigated the regulation of 5-LO mRNA expression by alternative
splicing and nonsense-mediated mRNA decay (NMD). In the present study, we report the identification of 2 truncated
transcripts and 4 novel 5-LO splice variants containing premature termination codons (PTC). The characterization of one of
the splice variants, 5-LOD3, revealed that it is a target for NMD since knockdown of the NMD factors UPF1, UPF2 and UPF3b
in the human monocytic cell line Mono Mac 6 (MM6) altered the expression of 5-LOD3 mRNA up to 2-fold in a cell
differentiation-dependent manner suggesting that cell differentiation alters the composition or function of the NMD
complex. In contrast, the mature 5-LO mRNA transcript was not affected by UPF knockdown. Thus, the data suggest that the
coupling of alternative splicing and NMD is involved in the regulation of 5-LO gene expression.
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Introduction
5-Lipoxygenase (arachidonate:oxygen 5-oxido-reductase) is the
key enzyme in the biosynthesis of LTs which represent mediators
of inflammatory and allergic reactions that are synthesized and
released after cell stimulation [1,2]. Several studies have shown
that 5-LO and LTs play a central role in asthma and inflammatory
disorders, vascular diseases and cancer [3]. 5-LO is mainly
expressed in mature leukocytes which is in agreement with the
function of LTs as mediators of immune reactions. Granulocytes,
monocytes/macrophages, mast cells, dendritic cells and B-
lymphocytes express 5-LO whereas platelets, endothelial cells, T-
cells and erythrocytes are 5-LO negative. In the skin, Langerhans
cells strongly express 5-LO [4]. During myeloid cell maturation,
expression of 5-LO mRNA and protein is strongly upregulated by
calcitriol and transforming growth factor-b (TGFb) in a promoter-
independent manner [5,6,7].
The existence of 5-LO splice variants was first described by
Black and co-workers in human brain tumors [8]. Using Northern
blot analysis they have shown that the 5-LO gene is expressed as a
multi-transcript family (2.7, 3.1, 6.4 and 8.6 kb) in human brain
tumors and in dimethyl sulfoxide-differentiated HL-60 cells.
Furthermore, the abundance of 5-LO transcripts was correlated
with the malignancy of the brain tumors. Accordingly, it was
hypothesized that the 5-LO splice variants play a role in human
tumor induced brain edemas. A recent study has investigated
whether splice variants of 5-LO exist in human leukocytes.
Boudreau et al. described two novel 5-LO protein isoforms in
human leukocytes that are generated from transcripts lacking exon
13 and parts of exon 10, respectively. Both isoforms are
catalytically inactive and inhibit the biosynthetic capacity of wild
type (WT) 5-LO in cells. It was suggested that these 5-LO isomers
might act as endogenous 5-LO inhibitor that could be involved in
the regulation of LT biosynthesis in vivo [9].
Alternative splicing is responsible for the generation of multiple
transcripts from a single gene. It has been shown that about half of
the genes of the human genome are alternatively spliced whereas
RNA arrays and sequencing data indicated that even up to 94% of
all human genes might be alternatively spliced [10,11]. About one
third of all alternatively spliced genes result in nonsense transcripts
containing PTCs. These splice variants can be subsequently
subjected to NMD which is a surveillance mechanism that
selectively degrades nonsense transcripts [12,13]. Upon demand,
a change in the splicing pattern will immediately result in the
mature transcript. Thus, gene expression can be regulated post-
transcriptionally by generating alternatively spliced transcripts
which are degraded by NMD but can rapidly switch to productive
splicing by changing the splicing pattern. The coupling of
alternative splicing and NMD seems to represent a widely
occurring mechanism by which gene expression is controlled
[13]. Brenner and co-workers have termed this process regulated
unproductive splicing and translation [12,13,14].
In the present study, we have identified novel splice variants of
5-LO in TGFb/calcitriol differentiated and undifferentiated MM6
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1cells. Studies with the protein biosynthesis inhibitor puromycin
and knockdown of individual NMD factors revealed that the splice
variant 5-LOD3, but not the WT 5-LO mRNA is regulated by
NMD in a UPF-dependent manner. Interestingly, the effects of the
knockdown of UPF1 and UPF3b on 5-LOD3 mRNA expression
are dependent on the differentiation status of the cells suggesting
that cell differentiation alters the composition or function of the
NMD complex.
Results
Identification and characterization of novel 5-LO splice
variants in TGFb and calcitriol differentiated and
undifferentiated MM6 cells
To investigate the existence of 5-LO splice variants, rapid
amplification of 59 cDNA ends (59 RACE) and reverse
transcription polymerase chain reaction (RT-PCR) was performed
with RNA isolated from undifferentiated and TGFb/calcitriol
differentiated MM6 cells. 59RACE revealed the presence of four 5-
LO splice variants (Fig. 1A). The most abundant variant 5-LOD3
completely lacks exon 3. In a second splice variant, the end of the
exon 1, the complete exon 2 and the beginning of exon 3 (5-
LOp1D2p3) was deleted. In addition, we identified two transcripts
with an alternative transcription initiation site within exon 4 (5-LO
Exon 4) and intron 4 (5-LO Intron 4), respectively.
RT-PCR was carried out to confirm the results from the 59
RACE and to detect 5-LO splice variants in a more downstream
region of the gene. To this aim, eight primer pairs (A–G, Fig. S1)
were designed which cover the complete 5-LO gene. The analysis
of the first five exons confirmed the existence of 5-LOD3 (Fig. 1B).
RT-PCR revealed further alternatively spliced transcripts in the 39
part of the 5-LO gene, one with an intron 10 retention (5-LOa10)
as already described [9], one with an intron 10 retention and
deletion of exons 11, exon 12 and the beginning of exon 13 (5-
LOa10D11,12p13) and another splice variant lacking parts of
exon 10 and exon 11 (5-LOp10p11, Fig. 1B). No alternative
splicing was detected in the central part of the 5-LO transcript
using primer pair D (Fig. 1B). Figure 1A gives an overview on 5-
LO splice variants found via 59RACE and RT-PCR in MM6 cells.
Expression analysis of alternatively spliced 5-LO
transcripts in undifferentiated and TGFb/calcitriol
differentiated MM6 cells
The expression level of different splice variants was determined
by RT-PCR analysis. For this purpose MM6 cells were cultured in
the absence and presence of TGFb and calcitriol for 4 days. RNA
was isolated at different time points (0 h, 12 h, 1 d, 2 d, 3 d and
4 d) and analyzed for 5-LO mRNA by RT-PCR. In order to
detect the various 5-LO transcripts, the RNA was reverse
transcribed using random hexamer primers and PCR was carried
out with the primer pair C (exon 2 to exon 5) and E (exon 10 to
exon 14) to detect mature 5-LO transcripts and with the primer
pair G which allows detection of 5-LOD3 mRNA (Fig. S1).
Polyadenylated and spliced 5-LO mRNA was analyzed using
reverse transcription with oligo-dT priming and PCR with primer
pair F (exon 13 to 39UTR). The results displayed a strong
induction of 5-LO mRNA expression by TGFb and calcitriol as
previously described [6]. The time course of the induction of 5-LO
mRNA strongly depends on which part of the pre-mRNA is
analyzed (Fig. 2). For the proximal part of the transcript (exon 2 to
exon 5), the most prominent effect was obtained after 1 d whereas
the distal part (exon 10 to exon 14) was induced ,8.0-fold already
after 12 h. After 3 d a similar induction was observed with all
analyzed 5-LO mRNA species (,5.0-fold). Interestingly, the
mature (spliced and polyadenylated) 5-LO transcripts show a
delay in the induction and require 2 d of treatment with TGFb/
calcitriol for complete upregulation (Fig. 2A). In undifferentiated
MM6 cells no significant induction of correctly spliced 5-LO
mRNA was observed in the distal as well as the proximal part
(Fig. 2B).
Next, the splice variant 5-LOD3 was analyzed. It shows a
similar time course as the correctly spliced transcript (exon 2 to
exon 5) which suggests that cell differentiation by TGFb and
calcitriol does not affect splicing of exon 3 (Fig. 2C). Taken
together, the data show a rather rapid and strong upregulation of
correctly as well as alternatively spliced 5-LO primary transcripts
with PTC and a delay in the appearance of the mature
(polyadenylated) transcript.
NMD analysis of 5-LOD3 mRNA in undifferentiated and
TGFb/calcitriol differentiated MM6 cells
Since the upregulation of alternatively spliced 5-LO mRNAs
with PTCs preceded the induction of mature transcripts, we
wondered whether these mRNAs are degraded by NMD and
subsequently not subjected to the maturation process. Thus, we
investigated whether the most abundant alternatively spliced
transcript, 5-LOD3 is a substrate for NMD. This 5-LO splice
variant shows a frame shift in exon 4 which introduces a stop
codon into this exon. The stop codon is located more than 55
nucleotides upstream of the next exon-exon junction which
suggests that it represents a PTC [15] so that 5-LOD3 mRNA
could be a target of NMD.
To analyze this, we exposed 1 d differentiated and undifferen-
tiated MM6 cells to the protein synthesis inhibitor puromycin.
Puromycin leads to a strong accumulation of the alternative
transcript in undifferentiated cells (Fig. 3). Interestingly, 5-LOD3
was only slightly affected by puromycin in differentiated cells. The
mature 5-LO transcript was insensitive to puromycin in differen-
tiated as well as undifferentiated cells.
To prove whether 5-LOD3 was degraded by NMD, we knocked
down UPF1 by shRNA. UPF1 is an essential component of the
NMD machinery and its downregulation usually leads to an
upregulation of mRNAs which are targeted by NMD. The
lentiviral expression of a UPF1-specific shRNA resulted in a 79%
knockdown of UPF1 protein expression (Fig. 4A). The UPF1
knockdown resulted in a 2-fold increase in 5-LOD3 mRNA in
undifferentiated MM6 cells (Fig. 4B). In contrast, a significant
reduction of 5-LOD3 mRNA expression to ,30% was observed in
differentiated MM6 cells. As expected, the mature 5-LO transcript
was insensitive to UPF1 knockdown in undifferentiated as well as
in differentiated MM6 cells. The findings that 5-LOD3 mRNA is
slightly increased by puromycin treatment in differentiated MM6
cells and is downregulated upon UPF1 knockdown raises some
mechanistic questions since UPF1 is supposed to be a key
component in the NMD complex. To gain further insights into the
NMD of 5-LO mRNA in MM6 cells, we preformed knockdowns
of the NMD factors UPF2 and UPF3b.
The knockdown of UPF2 and UPF3b lead to a 66% and 88%
reduction of UPF2 and UPF3b protein expression, respectively
(Fig. 4A). UPF2 knockdown resulted in a 55% decrease in 5-LOD3
mRNA expression in undifferentiated MM6 cells. In contrast, only
a slight reduction of 5-LOD3 mRNA was observed in differen-
tiated cells (Fig. 4B). Opposite effects on 5-LOD3 mRNA
expression were detected when UPF3b was knocked down. Here,
5-LOD3 mRNA expression was not affected upon UPF3b
knockdown in undifferentiated MM6 cells, but a significant
5-Lipoxygenase and Alternative Splicing
PLoS ONE | www.plosone.org 2 February 2012 | Volume 7 | Issue 2 | e31363upregulation of 5-LOD3 transcript expression was obtained in
differentiated cells.
Western blot analysis of UPF proteins was performed in order to
investigate whether cell differentiation affects the expression of the
UPF proteins. No significant changes in UPF1 and UPF2
expression were observed during differentiation of the MM6
cells (Fig. 5). Interestingly, an about 2-fold increase in UPF3b
expression was detected when the cells were differentiated with
calcitriol and TGFb.
Discussion
Alternative splicing of 5-LO transcripts was observed when 5-
LO mRNA expression was investigated in human brain tumors
Figure 1. Identification of novel 5-LO splice variants in MM6 cells. (A) Schematic representation of the identified 5-LO splice variants. (B) RT-
PCR products obtained with primer pair C (exon 2 to exon 5), D (exon 5 to exon 10) and E (exon 10 to exon 14) separated on a 1.5% agarose gel.
Asterisks indicate the alternative splicing products whose existence was confirmed by at least one sequenced recombinant clone.
doi:10.1371/journal.pone.0031363.g001
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LO mRNA has been described in different cell lines and in
leukocytes [9]. Here, a comprehensive analysis of the 5-LO
splicing pattern demonstrated the existence of at least seven
alternatively spliced transcripts in MM6 cells. Interestingly,
induction of immature and/or alternatively spliced 5-LO
transcripts preceded the increase in mature 5-LO mRNA
following differentiation of MM6 cells by calcitriol and TGFb.
This is agreement with previous analyses where the induction of
immature 5-LO transcripts preceded the upregulation of mature
5-LO mRNA by both agents. We could recently show that
induction of 5-LO mRNA expression by calcitriol and TGFb is
mainly due to the stimulation of transcript elongation [7]. Since
correctly and alternatively spliced immature 5-LO transcripts are
upregulated with similar time courses it seems that both agents do
not affect the splicing process. Interestingly, upregulation of
mature 5-LO mRNA is significantly slower than the induction of
the immature 5-LO mRNA species. One possible explanation is
that alternatively spliced transcripts containing PTC could be
subjected to NMD before transcript maturation so that only the
regular transcripts accumulate after maturation. Thus, accumula-
tion of the mature 5-LO mRNA and degradation of the other
transcripts may be an explanation why only the mature 5-LO
mRNA is detected in differentiated leukocytes by Northern blot
[16]. Based on the ‘‘50–55 nucleotides’’- rule [15] all new 5-LO
splice variants reported here possess PTCs and may represent
NMD targets. To confirm the NMD hypothesis, the most
prominently expressed splice variant 5-LOD3 was characterized
in this study. Since NMD depends on mRNA translation, MM6
cells were treated with the protein biosynthesis inhibitor
puromycin. 5-LOD3 mRNA expression was significantly upregu-
lated by puromycin. Interestingly, the puromycin effect depended
on the differentiation status and an only slight increase in 5-LOD3
mRNA expression was found in differentiated MM6 cells.
Differentiation-dependent effects on 5-LOD3 mRNA expression
were also observed when NMD was inhibited by knockdown of
Figure 2. Quantification of alternatively and correctly spliced 5-LO mRNA. Time courses of 5-LO mRNA induction in MM6 cells cultured with
(diff) and without (undiff) TGFb (1 ng/ml) and calcitriol (50 nM). Total RNA was extracted and cDNA was prepared using random hexamer primers for
the PCR analysis of correctly spliced 5-LO pre-mRNA applying primer pair C (exon 2 to exon 5) and E (exon 10 to exon 14). 5-LOD3 mRNA was
determined by primer pair G. For the specific analysis of the mature 5-LO transcripts, the samples were reverse transcribed with oligo-dT priming and
the cDNA was amplified with primer pair F (exon 13 to 39UTR). b-actin mRNA served as constitutively expressed control. The relative changes to day 0
are given as the mean+SE of three independent experiments. Time courses of 5-LO mRNA in (A) differentiated and (B) undifferentiated MM6 cells.
(C) Time courses of 5-LOD3 mRNA in MM6 cells cultured with (diff) and without (undiff) TGFb (1 ng/ml) and calcitriol (50 nM). 5-LOD3 cDNA was
analyzed using primer pair G. For the analysis of correctly spliced 5-LO mRNA the primer pair C was used.
doi:10.1371/journal.pone.0031363.g002
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mRNA expression in undifferentiated MM6 cells whereas a
significant decrease was observed in differentiated MM6 cells
(Fig. 4B). UPF2 knockdown resulted in a significant downregula-
tion of 5-LOD3 mRNA expression in undifferentiated cells as well
as to a weaker extend in differentiated MM6 cells (Fig. 4B). UPF3b
knockdown did not affect 5-LOD3 mRNA expression in
undifferentiated MM6 but lead to a significant upregulation in
differentiated cells (Fig. 4B). All the data suggest that 5-LOD3
mRNA expression is regulated by NMD. According to the general
model, one would expect that knockdown of UPF proteins inhibits
NMD and leads to the upregulation of the transcript. One possible
explanation for our observations that UPF knockdown leads to
both up- and downregulation of 5-LOD3 mRNA expression is that
there are several alternative NMD pathways that are dependent
on cell differentiation. However, these cell differentiation-depen-
dent changes do not seem to be due to alterations in the expression
of the UPF proteins since we observed no change (UPF1, UPF2) or
an only up to 2-fold upregulation of UPF3b protein expression
after cell differentiation.
Alternative pathways of NMD have previously been proposed to
exist in mammalians, but the role of these alternative NMD
mechanisms has not been defined [17,18,19]. Gong et al. have
shown that differentiation of C2C12 myoblasts to myotubes is
accompanied with an increase in the efficiency of an alternative
NMD and a decreased efficiency of classical NMD [20]. Recent
studies suggest the existence of three different branches of NMD in
mammals. The first is independent of UPF2, it retains its normal
function when UPF2 is depleted [18]. In contrast, the second
branch is independent of the core proteins of the exon-junction
complex (EJC), but depends on the RNA-binding EJC protein
RNPS1 and UPF2 [18]. And finally, the third alternative NMD
mechanism is described as UPF3 independent [17].
Due to the different efficiencies of the components of the NMD
complex to mediate mRNA degradation and the dynamics in the
composition of the complex, it is not so surprising that the
knockdown of single components of the NMD-EJC leads to up- as
well as downregulation of the target mRNAs. Indeed, in a
genome-wide analysis of NMD targets, Wittman et al. identified
many genes that are differentially regulated by UPF1 and UPF2
knockdown in HeLa cells. Their findings suggest that UPF1 and
UPF2 specific NMD could exist in mammalian cells [21].
Also, cell differentiation-dependent changes in NMD were
observed with UPF2. It was found that NMD in differentiated cells
were only mildly affected in UPF2 null mice, suggesting that
UPF2-dependent NMD mainly occurs in proliferating cells like
undifferentiated MM6 [22].
In contrast to 5-LOD3, the mature 5-LO transcript encoding
the 5-LO protein does not contain a PTC and should not be
subjected to NMD. In agreement with this, expression of 5-LO
mRNA was not affected by puromycin treatment or by UPF
knockdown in differentiated as well as in undifferentiated MM6
cells. This is in line with previous data, where we found that the
protein biosynthesis inhibitor cycloheximide (which can also
impair NMD) does not alter 5-LO mRNA expression in MM6
cells [23]. Additionally, the mature 5-LO transcript was insensitive
to all UPF knockdowns in differentiated as well as undifferentiated
cells.
Taken together, we identified a series of novel 5-LO splice
variants in MM6 cells. Characterization of one of the most
abundant of these 5-LO splice variants, 5-LOD3, showed that it is
a NMD target. Our data suggest a model for post-transcriptional
regulation of 5-LO gene expression by coupling of nonsense
mediated mRNA decay and alternative splicing.
Materials and Methods
Cell culture
MM6 cells were obtained from DSMZ (DMSZ no. ACC124).
MM6 cells were grown in RPMI-1640 medium supplemented
with 10% (v/v) fetal calf serum (FCS, Biochrom AG), 100 mg/ml
streptomycin (PAA The Cell Culture Company), 100 U/ml
penicillin (PAA The Cell Culture Company), 16 non essential
amino acids (Sigma Aldrich), 10 mg/ml insulin, 1 mM oxalacetate
(AppliChem) and 1 mM sodium pyruvate (PAA The Cell Culture
Company). Cell culture was carried out in a humidified
atmosphere of 5% CO2 at 37uC. MM6 cells were differentiated
with 1 ng/ml TGFb and 50 nM calcitriol at 37uC, 6% CO2.
RNA extraction and RT-PCR
Total RNA was extracted from 3 million MM6 cells with
TRIzol Reagent (Invitrogen) and treated with Turbo DNase
(Ambion) according to the manufacturer’s instructions. 1.5 mgo f
DNase-treated RNA was used for first-strand cDNA synthesis
using random hexamer primer (Fermentas) and 200 U Super-
Script II reverse transcriptase (Invitrogen) in a reaction volume of
20 ml following manufacturer’s instructions. The RNA was
digested with 5 U RNAseH (New England Biolabs). The first-
strand cDNA was finally used as template for PCR reactions with
gene specific primers. PCR was carried out using 2.5 U Taq
polymerase (New England Biolabs) according to the manufactur-
er’s instructions with the addition of 50 mM betaine (Sigma
Aldrich).
1 mg total RNA was reverse transcribed using the iScript
TM
cDNA Synthesis Kit (Bio-Rad) to analyze mature 5-LO tran-
Figure 3. Effect of NMD inhibition by puromycin on 5-LOD3
splice variant and mature 5-LO transcript expression. The cells
were cultured with and without TGFb (1 ng/ml) and calcitriol (50 nM)
for 24 h. Differentiated and undifferentiated MM6 cells were cultured
for 24 h and finally treated with puromycin (300 mg/mL) for 8 h. Total
RNA was isolated and the cDNA was prepared by random hexamer
priming. The cDNA was amplified by PCR using primer pair G for the
analysis of 5-LOD3 mRNA. For RT-PCR analysis of the mature 5-LO
transcript (5-LO MT), the total RNA was reverse transcribed using oligo-
dT primers. PCR was performed using primer pair F and b-actin mRNA
served as constitutively expressed control. Variations in the expression
levels compared to non-treated samples (set as 1) are given as the
mean+SE of three or four independent experiments, *p,0.05.
doi:10.1371/journal.pone.0031363.g003
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PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e31363Figure 4. Individual knockdown of NMD factors in MM6 cells. (A) Western blot analysis of UPF1, UPF2 and UPF3b protein expression in MM6
cells with and without knockdown of UPF1, UPF2 and UPF3b, respectively. Cell lysates (50–250 mg protein) in SDS-PAGE loading buffer (56) were
separated by 10% SDS-PAGE and transferred to a nitrocellulose membrane by electro blotting. The membrane was incubated with UPF1, UPF2,
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2.5 U Taq polymerase (New England Biolabs) according to the
manufacturer’s instructions with the addition of 50 mM betaine
(Sigma Aldrich). The primers Exon13F and 39UTR-R were used
for specific amplification of mature 5-LO mRNA (according to
[23]). All primer sequences are listed in the Table S1.
Amplification of the different PCR products was preformed as
follows: each cycle consisted of denaturing at 95uC for 45 s,
depending on the primer pair the annealing temperature was
between 53 and 58uC for 60 s, and primer extension at 72uC for
45 s. The annealing temperature was individually adjusted. Cycle
numbers were minimized for each series of experiments in order to
keep the PCR reaction in the exponential phase and to avoid
saturation effects (5-LO specific primer: 30–35 cycles; actin 25
cycles).
One tenth of each PCR sample was analyzed by gel
electrophoresis in a 1.5% ethidiumbromide-stained agarose gel.
Images of the gels were digitally captured by an image analysis
system and the BIO-ID software (Vilber Lourmat).
59 Rapid amplification of cDNA ends (59RACE)
12 mg DNase-treated total RNA was treated with 2 U alkaline
phosphatase (Roche Applied Science) for 1 h at 37uC according to
the manufacturer’s instructions. The RNA was purified by
phenol/chloroform/isoamyl alcohol (RotiH Phenol/Chloroform/
Isoamyl alcohol, Carl Roth), then treated with 30 U tobacco acid
pyrophosphatase (TAP, Epicentre Biotechnologies) for 90 min in
the supplied buffer and precipitated. TAP treatment was omitted
for a negative control. The sample was mixed with 400 pmol of a
40 nt RNA linker (Table S1). RNA ligation was performed in a
reaction volume of 20 ml using 5 U T4 RNA ligase 1 (New
England Biolabs) or 5 U T4 RNA ligase (Ambion) for 90 min in
the supplied buffer. 10 ml ligation product was reverse transcribed
using random hexamer primers (Fermentas), 200 U SuperScript II
reverse transcriptase (Invitrogen) and afterwards treated with 5 U
RNAse H (New England Biolabs). The cDNA library was used as
template for nested PCR with the linker specific and gene specific
primers (Table S1).
Cloning of PCR and 59RACE products
QIAquick Gel Extraction Kit (Qiagen) was used for gel
extraction of the RT- and 59RACE products. The isolated PCR
fragments were cloned into the pDrive cloning vector using the
Qiagen PCR Cloning
PLUS Kit (Qiagen) which allows blue/white
screening of recombinant colonies. The selected recombinant
plasmids were then sequenced.
Western blotting
Cells were lysed in phosphate buffered saline (PBS, PAA The
Cell Culture Company), 0.1% Triton X-100 (Fluka BioChemika),
1 mM phenyl methane sulfonyl fluoride (PMSF, Fluka BioChem-
ika) and centrifuged for 10 min (10,000 g, 4uC). The protein
content of the supernatant was determined by Bradford colori-
metric assay [24] (BioRad Laboratories). 50–250 mg protein lysate
was separated by SDS-PAGE (10%), transferred to a HyBond
ECL nitrocellulose membrane (Amersham) and blocked with
Odyssey blocking buffer (LI-CORH Bioscience) for 1 h at room
temperature. The membranes were then incubated over night at
4uC with primary antibodies that recognize 5-LO (BD Bioscience),
GAPDH (Cell Signaling), UPF1, UPF2, UPF3b (antiserum was
Figure 5. Western blot analysis of UPF protein expression in MM6 cells. Western blot analysis of UPF protein expression in MM6 cells
incubated with and without TGFb (1 ng/ml) and calcitriol (50 nM) for 24 h. Differentiation-dependent relative changes in UPF protein expression
compared to undifferentiated samples (set to 1) are given as the mean+SE of three independent experiments.
doi:10.1371/journal.pone.0031363.g005
UPF3b and b-actin antibody. Visualization of protein bands was carried out by the use of infrared dye-conjugated antibodies (IRDyeH), and analysis
was performed with the OdysseyH infrared imaging system (LI-CORH Biosciences). b-actin was used as loading control. The relative changes of UPF
knockdown samples to control samples (set as 1) are given as mean+SEM of three independent experiments, **p,0.01. (B) Effect of UPF knockdowns
on 5-LOD3 and mature 5-LO mRNA expression in MM6 cells. The cells were cultured with and without TGFb (1 ng/ml) and calcitriol (50 nM) for 24 h.
Then, total RNA was isolated and cDNA was prepared by random hexamer priming. PCR analysis was carried out using primer pair G for 5-LOD3. For
analysis of the mature 5-LO transcript, the total RNA was reverse transcribed using oligo-dT primers. PCR was performed using primer pair F and b-
actin mRNA served as constitutively expressed control. Variations in the expression levels compared to non-treated samples (set as 1) are given as the
mean+SE of three or four independent experiments, *p,0.05, **p,0.01.
doi:10.1371/journal.pone.0031363.g004
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California San Diego) and b-actin (Santa Cruz Biotechnology).
Membranes were washed with PBS pH 7.4/Tween20 0.1% (v/v)
(Carl Roth) and incubated with infrared dye conjugated secondary
andibodies (IRDyeH, LI-CORH Bioscience) for 45 min at room
temperature. Visualization and quantitative analysis was carried
out with the Odyssey Infrared Imaging System (LI-CORH
Biosciences).
NMD inhibition by puromycin
MM6 cells were cultured with and without TGFb (1 ng/ml)
and calcitriol (50 nM) for 24 h. Differentiated and undifferentiated
MM6 cells were cultured for 24 h and finally treated with
puromycin (300 mg/mL, Alexis Corporation) for 8 h as described
[25].
shRNA-mediated knockdown of UPF factors in MM6 cells
A lentiviral expression system for shRNA expression was used for
UPF1 knockdown. The MISSION shRNA plasmid for UPF1
knockdown (NM_002911.2-2451s1c1, TRCN0000022257), for UPF2
knockdown (NM_015542.2-1035s1c1, TRCN0000151381) and for
UPF3b knockdown (NM_023010.2-1007s1c1, TRCN0000152769)
was obtained from Sigma Aldrich. For the generation of lentiviral
particles HEK293T cells were transfected with 10 mgo ft h es h R N A
plasmid and 10 mg packaging plasmids (VSVG) by the calcium
phosphate method [26]. The medium was changed after 4 h and cells
were cultured for 72 h. For transduction, MM6 cells were supplement-
ed with protamine sulphate (4 mg/ml, Calbiochem). 500 mlo ft h ev i r a l
supernatant were added to cell suspension and centrifuged (2500 rpm,
90 min, 32uC). The transduced cells were grown for two days before
puromycin was added (0.75 mg/ml) to select the transduced clones.
After three weeks, knockdown efficiency of UPF factors was analyzed by
Western blot.
Statistics
Results are given as mean+SEM of three or four independent
experiments. Statistical analysis was carried out by Student’s
paired t test (two-tailed) using GraphPad Prism 5.0. Differences
were considered as significant for p,0.05 (indicated as * for
p,0.05, and ** for p,0.01).
Supporting Information
Figure S1 Location of the primer pairs used for the
59RACE and RT-PCR analysis (indicated with letters A to
G) on the 5-LO cDNA.
(TIF)
Table S1 Primer sequences.
(DOC)
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